• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

中国和韩国应对 COVID-19 政策的差异。

Policy Disparities in Response to COVID-19 between China and South Korea.

机构信息

Department of Health Management, School of Health Management, Southern Medical University, Guangzhou, Guangdong 510515, P.R. China.

Department of Health Policy and Management, Bloomberg School of Public Health, Johns Hopkins University, Baltimore, MD 21205, USA.

出版信息

J Epidemiol Glob Health. 2021 Jun;11(2):246-252. doi: 10.2991/jegh.k.210322.001. Epub 2021 Mar 29.

DOI:10.2991/jegh.k.210322.001
PMID:33876595
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8242108/
Abstract

OBJECTIVES

This study analyzed the effects of COVID-19 non-pharmaceutical measures between China and South Korea to share experiences with other countries in the struggle against SARS-CoV-2.

METHODS

We used the generalized linear model to examine the associations between non-pharmaceutical measures adopted by China and South Korea and the number of confirmed cases. Policy disparities were also discussed between these two countries.

RESULTS

The results show that the following factors influence the number of confirmed cases in China: lockdown of Wuhan city (LWC); establishment of a Leading Group by the Central Government; raising the public health emergency response to the highest level in all localities; classifying management of "four categories of personnel"; makeshift hospitals in operation (MHIO); pairing assistance (PA); launching massive community screening (LMCS). In South Korea, these following factors were the key influencing factors of the cumulative confirmed cases: raising the public alert level to orange (three out of four levels); raising the public alert to the highest level; launching drive-through screening centers (LDSC); screening all members of Shincheonji religious group; launching Community Treatment Center (LCTC); distributing public face masks nationwide and quarantining all travelers from overseas countries for 14 days.

CONCLUSION

Based on the analysis of the generalized linear model, we found that a series of non-pharmaceutical measures were associated with contain of the COVID-19 outbreak in China and South Korea. The following measures were crucial for both of them to fight against the COVID-19 epidemic: a strong national response system, expanding diagnostic tests, establishing makeshift hospitals, and quarantine or lockdown affected areas.

摘要

目的

本研究分析了中国和韩国在 COVID-19 非药物措施方面的效果,旨在与其他国家分享抗击 SARS-CoV-2 的经验。

方法

我们使用广义线性模型来检验中国和韩国采取的非药物措施与确诊病例数之间的关联。还讨论了这两个国家之间的政策差异。

结果

结果表明,以下因素影响了中国的确诊病例数:武汉封城(LWC);中央政府成立领导小组;在所有地方将公共卫生应急响应提高到最高级别;对“四类人员”进行分类管理;运营临时医院(MHIO);配对援助(PA);开展大规模社区筛查(LMCS)。在韩国,以下因素是累计确诊病例的关键影响因素:将公共警报级别提高到橙色(四级中的三级);将公共警报提高到最高级别;启动免下车筛查中心(LDSC);对新天地教会所有成员进行筛查;启动社区治疗中心(LCTC);在全国范围内分发公共口罩,并对所有来自海外国家的旅行者进行 14 天的隔离。

结论

基于广义线性模型的分析,我们发现一系列非药物措施与中国和韩国 COVID-19 疫情的控制有关。以下措施对两国抗击 COVID-19 疫情至关重要:强大的国家应对系统、扩大诊断检测、建立临时医院以及对受影响地区进行隔离或封锁。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/579c/8242108/62e875dbe4bc/JEGH-11-2-246-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/579c/8242108/70554a68a202/JEGH-11-2-246-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/579c/8242108/62e875dbe4bc/JEGH-11-2-246-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/579c/8242108/70554a68a202/JEGH-11-2-246-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/579c/8242108/62e875dbe4bc/JEGH-11-2-246-g002.jpg

相似文献

1
Policy Disparities in Response to COVID-19 between China and South Korea.中国和韩国应对 COVID-19 政策的差异。
J Epidemiol Glob Health. 2021 Jun;11(2):246-252. doi: 10.2991/jegh.k.210322.001. Epub 2021 Mar 29.
2
Policy disparities in response to the first wave of COVID-19 between China and Germany.中国和德国在应对新冠疫情第一波冲击时的政策差异。
Int J Equity Health. 2021 Mar 25;20(1):86. doi: 10.1186/s12939-021-01424-3.
3
Understanding South Korea's Response to the COVID-19 Outbreak: A Real-Time Analysis.了解韩国应对 COVID-19 疫情的情况:实时分析。
Int J Environ Res Public Health. 2020 Dec 21;17(24):9571. doi: 10.3390/ijerph17249571.
4
Policy disparities in response to COVID-19 between Singapore and China.新加坡和中国对 COVID-19 的政策差异。
Int J Equity Health. 2021 Aug 17;20(1):185. doi: 10.1186/s12939-021-01525-z.
5
The Impact of COVID-19 Management Policies Tailored to Airborne SARS-CoV-2 Transmission: Policy Analysis.《基于 SARS-CoV-2 空气传播的新冠管理政策的影响:政策分析》。
JMIR Public Health Surveill. 2021 Apr 21;7(4):e20699. doi: 10.2196/20699.
6
Coping with COVID-19: Core Elements of Lockdown Wuhan City Policy.应对 COVID-19:封锁武汉市政策的核心要素。
J Health Care Poor Underserved. 2021;32(1):373-385. doi: 10.1353/hpu.2021.0029.
7
Flattening the Curve on COVID-19: South Korea's Measures in Tackling Initial Outbreak of Coronavirus.新冠肺炎疫情曲线趋平:韩国应对冠状病毒初始爆发的措施。
Am J Epidemiol. 2021 Apr 6;190(4):496-505. doi: 10.1093/aje/kwaa217.
8
Policy disparities in fighting COVID-19 among Japan, Italy, Singapore and China.抗击新冠疫情中,日本、意大利、新加坡和中国的政策差异。
Int J Equity Health. 2021 Jan 13;20(1):33. doi: 10.1186/s12939-020-01374-2.
9
Responding to COVID-19 Among U.S. Military Units in South Korea: The U.S. Forces Korea's Operation Kill the Virus.美国驻韩军事单位应对 COVID-19:驻韩美军的“抗疫行动”。
Mil Med. 2022 Jan 4;187(1-2):e138-e146. doi: 10.1093/milmed/usab013.
10
Searching for Digital Technologies in Containment and Mitigation Strategies: Experience from South Korea COVID-19.搜索遏制和缓解策略中的数字技术:来自韩国 COVID-19 的经验。
Ann Glob Health. 2020 Aug 31;86(1):109. doi: 10.5334/aogh.2993.

引用本文的文献

1
Political orientation and COVID-19 policy preferences during the early pandemic: a comparative analysis of China and South Korea.疫情初期的政治倾向与新冠疫情政策偏好:中国与韩国的比较分析
Front Public Health. 2025 Jul 16;13:1581798. doi: 10.3389/fpubh.2025.1581798. eCollection 2025.
2
The ongoing impact of policy documents on the pandemic based on the framework of the "4Rs" theory and policy tools: in China.基于“4R”理论框架和政策工具的政策文件对中国疫情的持续影响
BMC Public Health. 2025 May 24;25(1):1926. doi: 10.1186/s12889-025-22504-x.
3
Real-world clinical outcomes of tixagevimab/cilgavimab in the Omicron outbreak in China: baseline characteristics and interim analysis of the CLEAR study.

本文引用的文献

1
Countries of origin of imported COVID-19 cases into China and measures to prevent onward transmission.中国输入性 COVID-19 病例的来源国及防控传播的措施。
J Travel Med. 2020 Dec 23;27(8). doi: 10.1093/jtm/taaa139.
2
Operating Protocols of a Community Treatment Center for Isolation of Patients with Coronavirus Disease, South Korea.韩国社区治疗中心对冠状病毒病患者进行隔离的操作方案。
Emerg Infect Dis. 2020 Oct;26(10):2329-2337. doi: 10.3201/eid2610.201460. Epub 2020 Jun 22.
3
South Korea's responses to stop the COVID-19 pandemic.
在中国奥密克戎疫情期间替沙格韦单抗/西加韦单抗的真实世界临床结局:CLEAR 研究的基线特征和中期分析。
Virol J. 2024 Oct 24;21(1):262. doi: 10.1186/s12985-024-02509-5.
4
The impact of containment policy and mobility on COVID-19 cases through structural equation model in Chile, Singapore, South Korea and Israel.结构方程模型分析智利、新加坡、韩国和以色列的遏制政策和流动性对 COVID-19 病例的影响。
PeerJ. 2023 Aug 1;11:e15769. doi: 10.7717/peerj.15769. eCollection 2023.
5
Primary care provider's job satisfaction and organizational commitment after COVID-19 restrictions ended: A mixed-method study using a mediation model.新冠疫情限制措施结束后基层医疗服务提供者的工作满意度与组织承诺:一项采用中介模型的混合方法研究
Front Psychol. 2022 Oct 13;13:873770. doi: 10.3389/fpsyg.2022.873770. eCollection 2022.
6
Ensuring sufficient cabin hospital beds for curbing the spread of COVID-19 - Findings from petri net analysis.确保有足够的方舱医院床位以遏制新冠病毒传播——基于Petri网分析的研究结果
Heliyon. 2022 Oct;8(10):e11202. doi: 10.1016/j.heliyon.2022.e11202. Epub 2022 Oct 21.
7
The Advantages of the Zero-COVID-19 Strategy.中国“动态清零”总方针的优势
Int J Environ Res Public Health. 2022 Jul 19;19(14):8767. doi: 10.3390/ijerph19148767.
8
Containment strategy during the COVID-19 pandemic among three Asian low and middle-income countries.新冠疫情期间三个亚洲中低收入国家的防控策略。
J Glob Health. 2022 May 21;12:05016. doi: 10.7189/jogh.12.05016.
9
The Geographical Distribution and Influencing Factors of COVID-19 in China.中国新冠肺炎的地理分布及影响因素
Trop Med Infect Dis. 2022 Mar 6;7(3):45. doi: 10.3390/tropicalmed7030045.
韩国应对新冠疫情大流行的措施。
Am J Infect Control. 2020 Sep;48(9):1080-1086. doi: 10.1016/j.ajic.2020.06.003. Epub 2020 Jun 6.
4
Active case finding with case management: the key to tackling the COVID-19 pandemic.主动病例发现与病例管理:应对 COVID-19 大流行的关键。
Lancet. 2020 Jul 4;396(10243):63-70. doi: 10.1016/S0140-6736(20)31278-2. Epub 2020 Jun 4.
5
[Roles of the public-facility-turned temporary hospital in prevention and control of coronavirus disease 2019 in Wuhan, China and clinical experience in the hospital].[武汉由公共设施改建的临时医院在2019冠状病毒病防控中的作用及医院临床经验]
Zhongguo Dang Dai Er Ke Za Zhi. 2020 May;22(5):409-413. doi: 10.7499/j.issn.1008-8830.2003228.
6
"Pairing assistance": the effective way to solve the breakdown of health services system caused by COVID-19 pandemic.“配对协助”:解决 COVID-19 大流行导致的卫生服务系统崩溃的有效方法。
Int J Equity Health. 2020 May 15;19(1):68. doi: 10.1186/s12939-020-01190-8.
7
COVID-19 in South Korea.韩国的 COVID-19 疫情。
Postgrad Med J. 2020 Jul;96(1137):399-402. doi: 10.1136/postgradmedj-2020-137738. Epub 2020 May 4.
8
Association of Public Health Interventions With the Epidemiology of the COVID-19 Outbreak in Wuhan, China.公共卫生干预措施与中国武汉 COVID-19 疫情流行病学的关联。
JAMA. 2020 May 19;323(19):1915-1923. doi: 10.1001/jama.2020.6130.
9
Out-of-Hospital Cohort Treatment of Coronavirus Disease 2019 Patients with Mild Symptoms in Korea: an Experience from a Single Community Treatment Center.韩国单社区治疗中心对新冠肺炎轻症患者的院外队列治疗:一项经验研究。
J Korean Med Sci. 2020 Apr 6;35(13):e140. doi: 10.3346/jkms.2020.35.e140.
10
An investigation of transmission control measures during the first 50 days of the COVID-19 epidemic in China.中国 COVID-19 疫情前 50 天的传播控制措施调查。
Science. 2020 May 8;368(6491):638-642. doi: 10.1126/science.abb6105. Epub 2020 Mar 31.